Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension.

Abstract

Burchill, L.J., Velkoska, E., Dean, R.G., Griggs, K., Patel, S.K., and Burrell, L.M. (2012). Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Clin Sci 123, 649–658. Article Google Scholar Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513. Article Google Scholar Fang, L., Karakiulakis, G., and Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8, e21. Article Google Scholar Fu, Y., Cheng, Y., and Wu, Y. (2020). Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin 35, 266–271. Article Google Scholar Jiang, F., Yang, J., Zhang, Y., Dong, M., Wang, S., Zhang, Q., Liu, F.F., Zhang, K., and Zhang, C. (2014). Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets. Nat Rev Cardiol 11, 413–426. Article Google Scholar Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al. (2020). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63, 364–374. Article Google Scholar Lopez Santi, R.G., Valeff, E.C., Duymovich, C.R., Mazziotta, D., Mijailovsky, N.E., Filippa, G.C., Maltez, R., Hernandez, V.A., Monroy, A.G., Borzi, J.G., et al. (2005). Effects of an angiotensinconverting enzyme inhibitor (ramipril) on inflammatory markers in secondary prevention patients: RAICES Study. Coronary Artery Dis 16, 423–429. Article Google Scholar Ruan, Q., Yang, K., Wang, W., Jiang, L., and Song, J. (2020). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46, 846–848. Article Google Scholar Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061–1069. Article Google Scholar Yang, J.M., Meng, X., Xue, F., Zhang, Y., and Zhang, C. (2020). ACE2 in the context of 2019-nCoV infection: friend or foe? Zhonghua Xin Xue Guan Bing Za Zhi 48, 527–531. PubMed Google Scholar Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273. Article Google Scholar Download references We thank all patients involved in this study. This study was supported by the Program of Introducing Talents of Discipline to Universities (BP 0719033), the State Key Program of the National Natural Science Foundation of China (81530014) and the International Collaboration and Exchange Program of China (81920108003). The Key Laboratory of Cardiovascular Remodeling and Function Research, Ministry of Education of China, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China Xiao Meng, Chenchen Wei, Kai Zhang, Ming Zhong, Cheng Zhang & Yun Zhang Department of Infectious Disease, Renmin Hospital of Wuhan University, Wuhan, 430060, China Xiao Meng, Kai Zhang & Yi Zhang Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, 430060, China Ya Liu Department of Respiratory Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China Yi Zhang You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar Correspondence to Cheng Zhang or Yun Zhang. The author(s) declare that they have no conflict of interest. Reprints and Permissions Meng, X., Liu, Y., Wei, C. et al. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension. Sci. China Life Sci. (2020). https://doi.org/10.1007/s11427-020-1813-0 Download citation Received: 19 July 2020 Accepted: 01 September 2020 Published: 21 September 2020 DOI: https://doi.org/10.1007/s11427-020-1813-0